Funding Cut Deepens Overdose Friction in North Carolina
The US federal government terminated funding for fentanyl, xylazine, and medetomidine test strips in April 2026, directly impacting overdose prevention efforts in North Carolina. This move reduced national funding for overdose prevention by over $300 million and eliminated the $15,000 annual support for organizations like ekiM for Change that distributed these tools. SAMHSA—the sole federal source for such test strips in North Carolina—was forced to stop funding, leaving communities without a low-cost ($1–$1.50 per unit) method to detect lethal contaminants in street drugs. The crisis intensifies as North Carolina’s Street Drug Analysis Lab has identified 500 unique substances in street drugs since 2022, with new compounds emerging annually. Without SAMHSA’s funding, people facing overdoses from contaminated drugs lose access to life-saving tests, increasing preventable deaths.
This friction directly threatens the health security of vulnerable populations. The funding cut removes a critical barrier to harm reduction, especially as street drug complexity grows. What to watch: The University of North Carolina-Chapel Hill’s lab continues detecting new substances, but SAMHSA’s spectroscopy machines may miss contaminants detectable by simpler test strips—a gap that could worsen outcomes if funding isn’t restored. The $300 million national cut reflects systemic strain on overdose prevention, yet the $15,000 annual figure shows how small organizations rely on federal support to bridge this gap. Without it, communities face higher overdose deaths as street drug risks escalate.
Source: KFF Health News
Many Minded